Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy

European Urology

Volumn 51, Issue 3, 2007, Pages 699-708

  Nielsen, Matthew E ^a   Shariat, Shahrokh F ^b   Karakiewicz, Pierre I ^c   Lotan, Yair ^b   Rogers, Craig G ^a   Amiel, Gilad E ^d   Bastian, Patrick J ^a   Vazina, Amnon ^d   Gupta, Amit ^b   Lerner, Seth P ^d   Sagalowsky, Arthur I ^b   Schoenberg, Mark P ^a   Palapattu, Ganesh S ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Age; Bladder cancer; Cystectomy; Recurrence; Survival

Indexed keywords

ADULT; AGE; AGED; AGING; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRANSITIONAL CELL CARCINOMA; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 33846209208     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.11.004     Document Type: Article

References (19)

1. Jemal A., Clegg L.X., Ward E., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101 (2004) 3-27
2. U.S. Bureau of the Census. Census USBot: projections of the population of the United States by age, sex and race, 1988-2080, current population reports, population estimates and projections, series p-25. Washington, D.C.: U.S. Bureau of the Census, U.S. Department of Commerce; 1991. p. 1-25.
3. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19 (2001) 666-675
4. Soulie M., Straub M., Game X., et al. A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer. J Urol 167 (2002) 1325-1328
5. Stroumbakis N., Herr H.W., Cookson M.S., et al. Radical cystectomy in the octogenarian. J Urol 158 (1997) 2113-2117
6. Chang S.S., Alberts G., Cookson M.S., et al. Radical cystectomy is safe in elderly patients at high risk. J Urol 166 (2001) 938-941
7. Thrasher J.B., Frazier H.A., Robertson J.E., et al. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 73 (1994) 1708-1715
8. Clark P.E., Stein J.P., Groshen S.G., et al. Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer 103 (2005) 546-552
9. Hollenbeck B.K., Miller D.C., Taub D., et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 64 (2004) 292-297
10. Prout Jr. G.R., Wesley M.N., Yancik R., et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients. Cancer 104 (2005) 1638-1647
11. Shariat S.F., Khoddami S.M., Saboorian H., et al. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J Urol 171 (2004) 1122-1127
12. Lotan Y., Gupta A., Shariat S., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
13. Fleshner N.E., Herr H.W., Stewart A.K., et al. The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Database report on bladder carcinoma. Cancer 78 (1996) 1505-1513
14. Snyder C., Harlan L., Knopf K., et al. Patterns of care for the treatment of bladder cancer. J Urol 169 (2003) 1697-1701
15. Konety B.R., and Joslyn S.A. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170 (2003) 1765-1771
16. Koch M.O., and Smith Jr. J.A. Influence of patient age and co-morbidity on outcome of a collaborative care pathway after radical prostatectomy and cystoprostatectomy. J Urol 155 (1996) 1681-1684
17. Game X., Soulie M., Seguin P., et al. Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol 39 (2001) 525-529
18. Miller D.C., Taub D.A., Dunn R.L., et al. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol 169 (2003) 105-109
19. Liedberg F., and Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 49 (2006) 13-21